BE1005473A3 - Derives heterocycliques. - Google Patents

Derives heterocycliques. Download PDF

Info

Publication number
BE1005473A3
BE1005473A3 BE9201065A BE9201065A BE1005473A3 BE 1005473 A3 BE1005473 A3 BE 1005473A3 BE 9201065 A BE9201065 A BE 9201065A BE 9201065 A BE9201065 A BE 9201065A BE 1005473 A3 BE1005473 A3 BE 1005473A3
Authority
BE
Belgium
Prior art keywords
alkyl
formula
radical
alkoxy
phenyl
Prior art date
Application number
BE9201065A
Other languages
English (en)
French (fr)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Application granted granted Critical
Publication of BE1005473A3 publication Critical patent/BE1005473A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE9201065A 1991-12-04 1992-12-03 Derives heterocycliques. BE1005473A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125842A GB9125842D0 (en) 1991-12-04 1991-12-04 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
BE1005473A3 true BE1005473A3 (fr) 1993-08-03

Family

ID=10705730

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9201065A BE1005473A3 (fr) 1991-12-04 1992-12-03 Derives heterocycliques.

Country Status (10)

Country Link
JP (1) JPH05255327A (it)
BE (1) BE1005473A3 (it)
CA (1) CA2082668A1 (it)
DE (1) DE4239440A1 (it)
FR (1) FR2684672A1 (it)
GB (2) GB9125842D0 (it)
IE (1) IE922785A1 (it)
IT (1) IT1256320B (it)
NL (1) NL9202091A (it)
ZA (1) ZA928742B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439911A (en) * 1992-12-28 1995-08-08 Shionogi & Co., Ltd. Aminopyrimidine derivatives and their production and use
ES2126061T3 (es) * 1993-03-24 1999-03-16 American Home Prod Piridopirimidinas substituidas como antihipertensores.
KR100300566B1 (ko) * 1994-09-17 2001-11-22 조생현 피리미디논유도체와그의제조방법및용도
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
ES2346513T3 (es) 2000-07-24 2010-10-18 Krenitsky Pharmaceuticals, Inc. 5-alquinil pirimidinas sustituidas que tienen actividad neurotrofica.
GB0117396D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
PT1471057E (pt) 2003-04-25 2006-05-31 Actimis Pharmaceuticals Inc Derivados de acido pirimidinilacetico uteis para o tratamento de doencas mediadas por crth2
ATE433452T1 (de) 2004-01-31 2009-06-15 Actimis Pharmaceuticals Inc Imidazoä1,2-cüpyrimidinylessigsäurederivate
JP5524847B2 (ja) 2007-09-25 2014-06-18 アクチミス ファーマシューティカルズ インコーポレーテッド Ｃｒｔｈ２アンタゴニストとしてのアルキルチオピリミジン
US8314116B2 (en) 2007-09-25 2012-11-20 Actimis Pharmaceuticals, Inc. 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
KR102481705B1 (ko) * 2020-08-04 2022-12-27 연세대학교 산학협력단 트리아졸 유도체를 유효성분으로 포함하는 간 섬유증의 예방 또는 치료용 조성물
BR112023020442A2 (pt) * 2021-04-09 2023-11-21 Simcere Zaiming Pharmaceutical Co Ltd Inibidor da protease 1 específica de ubiquitina (usp1)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424317A2 (de) * 1989-10-19 1991-04-24 Ciba-Geigy Ag Pyrimidine
EP0475206A2 (en) * 1990-09-10 1992-03-18 Abbott Laboratories Angiotensin II receptor antagonists
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424317A2 (de) * 1989-10-19 1991-04-24 Ciba-Geigy Ag Pyrimidine
EP0475206A2 (en) * 1990-09-10 1992-03-18 Abbott Laboratories Angiotensin II receptor antagonists
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
IE922785A1 (en) 1993-06-16
GB2262096A (en) 1993-06-09
ZA928742B (en) 1993-06-09
JPH05255327A (ja) 1993-10-05
GB9125842D0 (en) 1992-02-05
NL9202091A (nl) 1993-07-01
CA2082668A1 (en) 1993-06-05
ITMI922661A1 (it) 1993-06-05
IT1256320B (it) 1995-11-30
GB9225283D0 (en) 1993-01-27
ITMI922661A0 (it) 1992-11-20
FR2684672A1 (fr) 1993-06-11
DE4239440A1 (it) 1993-06-09

Similar Documents

Publication Publication Date Title
AU2020309064B2 (en) Glucagon-like peptide 1 receptor agonists
BE1005473A3 (fr) Derives heterocycliques.
JP3182213B2 (ja) ピリミジンの新誘導体、それらの製造法、得られる中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
TW201124399A (en) Heteroaryl compounds and uses thereof
JP2012180369A (ja) 有機化合物
JP6278416B2 (ja) 置換４−ピリドン及びそれらの好中球エラスターゼ活性阻害薬としての使用
EP0991627B1 (en) Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
JPH03133964A (ja) ピリミジン誘導体
IL296916A (en) rip1k inhibitors
JP2008524210A (ja) メタロプロテイナーゼ阻害剤としての新規ヒダントイン誘導体
EP2020410B1 (fr) Dérivés de pyrido[2,3-d] pyrimidine, leur préparation, leur application en thérapeutique
KR20150114575A (ko) 치환된 바이사이클릭 디하이드로피리미디논 및 호중구 엘라스타제 활성의 억제제로서의 이의 용도
JP2020504170A (ja) 酸性基を含有するピリミジン化合物
JP6345337B2 (ja) 置換二環式ジヒドロピリミジノンおよび好中球エラスターゼ活性の阻害薬としてのそれらの使用
CA3198096A1 (en) Aryl derivatives for treating trpm3 mediated disorders
JPH0789957A (ja) ビフェニルメチルアミン誘導体
CN114478522A (zh) 一种吡啶并咪唑类衍生物及其制备方法与应用
US20160052937A1 (en) Tetrahydroimidazo[1,5-d][1,4]oxazepine compound
FR2842527A1 (fr) Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
EP2885297B1 (fr) Pyrido[3,2-d]pyrimidines trisubstituées, leurs procédés de préparation et leurs utilisations en thérapeutique
JP2837318B2 (ja) アンジオテンシンｉｉ拮抗性ピリジン誘導体
KR20170102360A (ko) 피라졸 화합물
WO1994011379A1 (en) Heterocyclic compounds as angiotensin ii antagonists
US6387915B2 (en) Isoxazole-sulfonamide endothelin antagonists
US6458821B1 (en) N-substituted azabicycloheptane derivatives, production and use thereof

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC.

Effective date: 19951231